Company intelligence / Profile preview

Probiotical

Novara, Piedmont, Italyprobiotical.com ↗

Ownership: Private
Employees: ~50
Development stage: Commercial

Overview

Probiotical offers a broad portfolio of clinically validated probiotic, synbiotic, and postbiotic formulations for diverse health applications. Their products are supported by scientific studies demonstrating efficacy in gastrointestinal health, immune modulation, mood improvement, skin conditions like atopic dermatitis, and sports performance. They do not market their own branded finished goods but supply ingredients/formulations to partners.

Therapeutic areas: GastroenterologyPsychiatryDermatologyOther
Modalities: Live biotherapeutic product therapyMicrobial therapySynbiotic therapy (probiotic + prebiotic)Postbiotic therapy
Industry: Non-Drug Biotech

Partnerships

Partners with globally leading pharmaceutical companies; specific names not disclosed

Beyond the preview

Go deeper on Probiotical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Probiotical.

Explore the full profile